Marketing-authorisation holder · United States
Apothecon
73 medicines in 1 country, as authorisation holder.
Group structure
Other companies in the group
Headquarters not stated1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
1–25 of 73
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AMIKIN250MG BASE/ML | 250MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 50MG BASE/ML | 50MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Amikacin | United States | Not marketed | 1981 |
| AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER10mg base/ml | 5mg base/ml · Injectable | Amikacin | United States | Not marketed | |
| BETAPEN-VK125mg base/5ml | 250mg base/5ml · For solution | Phenoxymethylpenicillin | United States | Not marketed | |
| CAPOZIDE 25/1525MG; 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Captopril, Hydrochlorothiazide | United States | Not marketed | 1984 |
| CAPOZIDE 25/2525MG; 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Captopril, Hydrochlorothiazide | United States | Not marketed | 1984 |
| CAPOZIDE 50/1550MG; 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Captopril, Hydrochlorothiazide | United States | Not marketed | 1984 |
| CAPOZIDE 50/2550MG; 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Captopril, Hydrochlorothiazide | United States | Not marketed | 1984 |
| CEFADYL1gm base/vial | 20gm base/vial | 2gm base/vial | 4gm base/vial | 500mg base/vial · Injectable | Cephapirin | United States | Not marketed | 1974 |
| DICLOXACILLIN SODIUM62.5mg base/5ml · For suspension | Dicloxacillin | United States | Not marketed | 1971 |
| DYNAPEN62.5mg base/5ml · For suspension | Dicloxacillin | United States | Not marketed | |
| FUNGIZONE50mg/vial · Injectable | Amphotericin b | United States | Not marketed | 1966 |
| FUNGIZONE3% · Ointment | Amphotericin b | United States | Not marketed | 1965 |
| FUNGIZONE3% · Cream | Amphotericin b | United States | Not marketed | 1966 |
| FUNGIZONE3% · Lotion | Amphotericin b | United States | Not marketed | 1964 |
| KANTREX500mg base · Capsule | Kanamycin | United States | Not marketed | 1987 |
| KANTREX1gm base/3ml | 500mg base/2ml | 75mg base/2ml · Injectable | Kanamycin | United States | Not marketed | 1973 |
| KENALOG-1010mg/ml · Injectable | Triamcinolone | United States | Marketed | 1960 |
| KENALOG-4040mg/ml · Injectable | Triamcinolone | United States | Marketed | 1965 |
| KENALOG-8080mg/ml · Injectable | Triamcinolone | United States | Marketed | 1965 |
| KLOTRIX10meq · Tablet, extended release | Potassium chloride | United States | Not marketed | 1980 |
| MUCOMYST10% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 20% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution | Acetylcysteine | United States | Not marketed | 1963 |
| NATURETIN-1010mg · Tablet | Bendroflumethiazide | United States | Not marketed | 1959 |
| NATURETIN-2.52.5mg · Tablet | Bendroflumethiazide | United States | Not marketed | 1959 |
| NATURETIN-55MG · Tablet | Bendroflumethiazide | United States | Not marketed | 1959 |
| OPHTHAINE0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution/drops | Proxymetacaine | United States | Not marketed | 1953 |